Item 8.01. Other Events.
On June 10, 2022, Global Blood Therapeutics, Inc. issued a press release titled
"GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further
Supporting Clinical Use of Oxbryta® (voxelotor) in Sickle Cell Disease." A copy
of the press release is attached as Exhibit 99.1 to this Current Report on Form
8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit Number Description
99.1 Press Release dated June 10, 2022
104 Cover Page Interactive Data File (embedded within the Inline
XBRL document)
© Edgar Online, source Glimpses